Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | STOXX® Europe 600 Health Care |
| Investment focus | Equity, Europe, Health Care |
| Fund size | GBP 616 m |
| Total expense ratio | 0.46% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | No |
| Fund currency | EUR |
| Currency risk | Currency unhedged |
| Volatility 1 year (in GBP) | 16.74% |
| Inception/ Listing Date | 25 April 2001 |
| Distribution policy | Distributing |
| Distribution frequency | At least annually |
| Fund domicile | Germany |
| Fund Provider | iShares |
| Fund Structure | Contractual Fund |
| UCITS compliance | Yes |
| Administrator | State Street Bank International GmbH |
| Investment Advisor | |
| Custodian Bank | State Street Bank International GmbH |
| Revision Company | Deloitte |
| Fiscal Year End | 1 March |
| Swiss representative | BlackRock Asset Management Schweiz AG |
| Swiss paying agent | State Street Bank International GmbH, Munich, Zurich Branch |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | No |
| Securities lending counterparty |
| Roche Holding AG | 15.90% |
| AstraZeneca PLC | 15.25% |
| Novartis AG | 15.25% |
| Novo Nordisk A/S | 5.83% |
| GSK Plc | 5.75% |
| Sanofi | 5.24% |
| EssilorLuxottica SA | 4.26% |
| Bayer AG | 2.34% |
| Lonza Group AG | 2.33% |
| Haleon | 2.30% |
| Switzerland | 36.97% |
| United Kingdom | 24.56% |
| France | 10.73% |
| Germany | 6.06% |
| Other | 21.68% |
| Health Care | 81.75% |
| Consumer Discretionary | 4.26% |
| Consumer Staples | 2.30% |
| Basic Materials | 0.99% |
| Other | 10.71% |
| YTD | -0.91% |
| 1 month | +0.17% |
| 3 months | -4.13% |
| 6 months | +2.27% |
| 1 year | +23.36% |
| 3 years | +10.87% |
| 5 years | +36.08% |
| Since inception (MAX) | +456.91% |
| 2025 | +12.85% |
| 2024 | -0.91% |
| 2023 | +5.94% |
| 2022 | -1.51% |
| Current dividend yield | 1.57% |
| Dividends (last 12 months) | GBP 1.55 |
| Period | Dividend in GBP | Dividend yield in % |
|---|---|---|
| 1 Year | GBP 1.55 | 1.91% |
| 2025 | GBP 1.56 | 1.73% |
| 2024 | GBP 1.32 | 1.44% |
| 2023 | GBP 1.46 | 1.66% |
| 2022 | GBP 1.35 | 1.48% |
| Volatility 1 year | 16.74% |
| Volatility 3 years | 14.97% |
| Volatility 5 years | 14.96% |
| Return per risk 1 year | 1.40 |
| Return per risk 3 years | 0.23 |
| Return per risk 5 years | 0.42 |
| Maximum drawdown 1 year | -13.40% |
| Maximum drawdown 3 years | -24.40% |
| Maximum drawdown 5 years | -24.40% |
| Maximum drawdown since inception | -42.37% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | EXV4 | - - | - - | - |
| Stuttgart Stock Exchange | EUR | EXV4 | - - | - - | - |
| SIX Swiss Exchange | EUR | SXDPEX | SXDPEX SE SXDPNAV | SXDPEX.S RXPXNAV.DE | |
| XETRA | EUR | EXV4 | SXDPEX GY SXDPNAV | SXDPEX.DE RXPXNAV.DE |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| Amundi STOXX Europe 600 Healthcare UCITS ETF Acc | 876 | 0.30% p.a. | Accumulating | Swap-based |